blank
blank

ERDERA Strategic Research and Innovation Agenda

1:1
The SRIA sets ERDERA’s objectives and performance indicators to guide rare disease research and innovation across Europe.

This Strategic Research and Innovation Agenda (SRIA) describes the SRIA development process and sets out the ambition, vision and mission of the European Rare Diseases Research Alliance (ERDERA). It defines ERDERA’s general, specific and operational objectives, and includes performance indicators for monitoring and evaluation.

Acces this publication
blank

publication

cover for the ERDERA Strategic Research and Innovation Agenda (2024)

Source

ERDERA

You might also be interested in

ERDERA CTC 2026

ERDERA Clinical Trial Call – Call Text

Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.
EU Flags

European Commission opens call for evidence on future Joint Undertakings

Feedback is open until 14 July 2026, giving stakeholders an early opportunity to comment during the preparation of a likely legislative proposal for a Council regulation.
image (3)

Event Report: 2nd International Conference on Clinical Research Networks (CRNs) for Rare Diseases

The 2nd International Conference on Clinical Research Networks (CRNs), organised by European Rare Diseases Research Alliance (ERDERA), Rare Disease International (RDI) and International Rare Diseases Research Consortium (IRDiRC), brought together the global rare disease community to advance innovative clinical research solutions, with a special focus on low- and middle-income countries (LMICs).
ECRD 2026

ECRD 2026 in Prague strengthens the push for a coordinated EU Action Plan on rare diseases

On 3–4 June, EURORDIS–Rare Diseases Europe and Orphanet convened the rare disease community at ECRD 2026 in Prague around a shared call for coordinated European action, including the forthcoming European Blueprint for Rare Diseases.

ERDERA's

search form